SNCA and Parkinson disease: In addition, several studies of the PD brain have demonstrated a loss of DNA methylation at the α-synuclein gene promoter, which may contribute to elevated α-synuclein expression; a major PD risk factor and a main component of Lewy pathology in this disease [38–41].